Summary
Activities of Gamma-aminobutyrate aminotransferase (GABA-T) and Monoamine oxidase (MAO)-A and-B were estimated in postmortem brains from 6 control subjects without psychiatric or neurologic disorders and 8 histopathologically verified cases of patients with Alzheimer's disease and senile dementia of Alzheimer type (AD/SDAT). The enzyme activities were examined in four cortical brain regions, three nuclei in the basal ganglia, thalamus and white matter. GABA-T activities in the cortical regions (frontal, parietal, occipital and temporal cortices) and nucleus caudatus were significantly lowered in the AD/SDAT patients. The MAO-A activities were significantly increased in the occipital cortex, caudate nucleus, thalamus and white matter in the AD/SDAT patients. No significant differences were found in the other regions (frontal cortex, parietal cortex, temporal cortex, putamen and globus pallidus). The MAO-B activities in three cortical regions (frontal, parietal and occipital cortices), thalamus and white matter were significantly increased in the AD/SDAT patients, whereas no difference was apparent in the other regions. The changed activities could not be correlated with age or postmortem time. The present results are the first describing decreased GABA-T activities as well as increased MAO-A activities in brain from patients with AD/SDAT, while the results with MAO-B support previous findings. A possible connection was found between the order of magnitude of the changes in enzyme activities and the severity of the disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adolfsson R, Gottfries CG, Oreland L, Wiberg Å, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034
Adolfsson R, Gottfries CG, Nyström L, Winblad B (1981) Prevalence of dementia disorders in institutionalised Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 63: 225–244
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed (revised). American Psychiatric Association, Washington DC,p 103
Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, Takahashi H, Hirokawa K, Tsumita T (1990) Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. Chem Pharm Bull 38: 1748–1749
Arai Y, Stenström A, Oreland L (1985) The effect of age on intra- and extraneuronal monoamine oxidase-A and-B activities in the rat brain. Biogenic Amines 2: 65–71
Arai H, Kobayashi K, Ichimiya Y, Kosaka K, Iizuka R (1985a) Free amino acids in postmortem cerebral cortices from patients with Alzheimer-type dementia. Neurosci Res 2: 486–490
Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S (1982) Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Arch Neurol 39: 709–712
Beal MF, Mazurek MF, Ellison DW, Kowall NW, Solomon PR, Pendlebury WW (1989) Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience 29: 339–346
Beal MF, MacGarvey U, Swartz KJ (1990) Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 28: 157–161
Blennow K (1990) Heterogeneity of Alzheimer's disease. Thesis, University of Gothenburg, Sweden
Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459–496
Bowen DM, Smith CB, White P, Goodhardt MJ, Spillane JA, Flack RHA, Davison AN (1977) Chemical pathology of the organic dementias, validity of biochemical measurements on human post-mortem brain specimens. Brain 100: 397–426
Coyle JT, Molliver ME, Kuhar MJ (1978) In site injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J Comp Neurol 180: 301–324
Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171: 319–327
Demarest KT, Smith DJ, Azzaro AJ (1980) The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons. J Pharmacol Exp Ther 215: 461–468
Eckert B, Gottfries CG, von Knorring L, Oreland L, Wiberg Å, Winblad B (1980) Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Prog Neuro Psychopharmacol 4: 57–68
Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB (1986) A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 20: 616–621
Enna SJ, Stern LZ, Wastek GJ, Yamamura HI (1977) Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. Arch Neurol 34: 683–685
Fowler CJ (1982) Selective inhibitors of monoamine oxidase types A and B and their clinical usefulness. Drugs Future 7: 501–517
Fowler CJ, Wiberg Å, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49: 1–20
Francis A, Pearce LB, Roth JA (1985) Cellular localisation of monoamine oxidase-A and B in brain: evidence from kainic acid lesions in striatum. Brain Res 334: 59–64
Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252
Gottfries CG (1990) Neurochemical aspects of dementia disorders. Dementia 1: 56–64
Gottfries CG (1990a) Differential diagnosis of early Alzheimer's disease. In: Dostert P, Riederer P, Strolin Benedetti M, Roncucci R (eds) Early markers in Parkinson's and Alzheimer's disease. Springer, Wien New York, pp 155–163
Gottfries CG, Oreland L, Wiberg Å, Winblad B, (1975) Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 25: 667–673
Hansson E (1990) Regional heterogeneity among astrocytes in the central nervous system. Neurochem Int 16: 237–245
Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Transmitter deficits in Alzheimer's disease. Neurochem Int 7: 545–563
Hardy J, Cowburn R, Barton A, Reynolds G, Dodd P, Wester P, O'Carroll AM, Löfdahl E, Winblad B (1987) A disorder of cortical GABAergic innervation in Alzheimer's disease. Neurosci Lett 73: 192–196
Jellinger K, Riederer P (1984) Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. In: Hassler RG, Christ JF (eds) Advances in neurology, 40. Raven Press, New York, pp 199–210
Jossan SS, Hiraga Y, Oreland L (1989) The cholinergic neurotoxin ethylcholine mustard aziridinium (AF64A) induces an increase in MAO-B activity in the rat brain. Brain Res 476: 291–297
Jossan SS, Gillberg PG, Gottfries CG, Karlsson I, Oreland L (1991) Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience 45: 1–12
Lloyd KG, Bossi L, Morselli PL, Rougier M, Loiseau P, Munari C (1985) Biochemical evidence for dysfunction of GABA neurons in human epilepsy. In: Bartholini G, Bossi L, Lloyd KG, Morselli PL (eds) Epilepsy and GABA receptors agonists: basic and therapeutic research. Raven Press, New York, pp 43–51
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Mackay AVP, Davies P, Dewar AJ, Yates CM (1978) Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 30: 827–839
Maitre M, Ossola L, Mandel P (1979) GABA-transaminase of mammalian brain. Adv Exp Med Biol 123: 3–20
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210
Mckhann G, Drackman D, Folstein M, Katzman R, Price D, Stadlan E M (1984) Clinical diagnoses of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939–944
Melamed E, Youdim MBH, Rosenthal J, Spanier I, Uzzan A, Globus M (1985) In vivo effect of MPTP on monoamine oxidase activity in mouse striatum. Brain Res 359: 360–363
Monfort JC, Javoy-Agid F, Hauw JJ, Dubois B, Agid Y (1985) Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 108: 301–313
Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H (1990) Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 80: 419–425
Oreland L, Gottfries CG (1986) Platelet and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog Neuro Psychopharmacol Biol Psychiatry 10: 533–540
Oreland L, Fowler CJ, Carlsson A, Magnusson T (1980) Monoamine oxidase-A and-B activity in the rat brain after hemitransection. Life Sci 26: 139–146
Oreland L, Arai Y, Stenström A, Fowler CJ (1983) Monoamine oxidase and localisation in the brain and the activity in relation to psychiatric disorders (In: MAO in psychiatric research). Med Probl Pharmacopsychiatry 19: 246–254
Oreland L, Hiraga Y, Jossan SS, Regland B, Gottfries CG (1990) Increased monoamine oxidase activity and vitamin B-12 deficiency in dementia disorders. In: Dostert P, Riederer P, Strolin Benedetti M, Roncucci R (eds) Early markers in Parkinson's and Alzheimer's disease. Springer, Wien New York, pp 267–286
Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 34: 247–265
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH(1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459
Perry EK, Perry RH, Tomlinson BE (1982) The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett 29: 303–307
Pomara N, Deptula D, Galloway MP, LeWitt PA, Stanley M (1989) CSF GABA in caregiver spouses of Alzheimer patients. Am J Psychiatry 146: 787–788
Regland B, Gottfries CG, Oreland L (1991) Vitamin B-12 induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anemia. Eur Arch Psychiatr Clin Neurosci 240: 288–291
Reinikainen KJ, Paljärvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245–252
Riederer P, Jellinger K (1983) Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline). Acta Neurol Scand 95: 43–55
Riederer P, Konradi C, Hebenstreit G, Youdim MBH (1989) Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand 126: 41–45
Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 105: 313–330
Rossor MN, Iversen LL (1986) Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Br Med Bull 42: 70–74
Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J 288: 961–964
Roth M (1986) The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. Br Med Bull 42: 42–50
Sasaki H, Muramoto O, Kanazawa I, Arai H, Kosaka K, Iizuka R (1986) Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type. Ann Neurol 19: 263–269
Schoepp DD, Azzaro AJ (1983) Effects of intrastriatal kainic acid injection of (3H) dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase. J Neurochem 40: 1340–1348
Sherif F, Eriksson L, Oreland L (1991) GABA-transaminase activity in rat and human brain: regional, age and sex-related differences. J Neural Transm 84: 95–102
Sherif F, Marcusson J, Oreland L (1991a) Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatr Clin Neurosci 241: 139–144
Stenström A, Arai Y, Oreland L (1985) Intra- and extraneuronal monoamine oxidase-A and-B activities after central axotomy (hemisection) on rats. J Neural Transm 61: 105–113
Teychenné PF, Ziegler MG, Lake CR, Enna SJ (1982) Low CSF GABA in parkinsonian patients who respond poorly to therapy or suffer from the “on-off” phenomenon. Ann Neurol 11: 76–79
Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci II: 205–242
Van Kammen DP, Sternberg DE, Hare TA, Waters RN, Bunney WE (1982) CSF levels of gamma-aminobutyric acid in schizophrenia. Arch Gen Psychiatry 39: 91–97
White HL, Faison LD (1980) GABA-T in blood platelets: comparison with GABA-T of other tissues. Brain Res Bull 5: 115–119
Zimmer R, Teelken AW, Trieling WB, Weber W, Weihmayr T, Lauter H (1984) Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of the Alzheimer's type. Arch Neurol 41: 602–604
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sherif, F., Gottfries, C.G., Alafuzoff, I. et al. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm Gen Sect 4, 227–240 (1992). https://doi.org/10.1007/BF02260906
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02260906